| The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma K Troppan, A Deutsch, A Gerger, T Stojakovic, C Beham-Schmid, K Wenzl, ... British journal of cancer 110 (2), 369-374, 2014 | 108 | 2014 |
| The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms K Wenzl, K Troppan, P Neumeister, A JA Deutsch Current drug targets 16 (1), 38-46, 2015 | 77 | 2015 |
| Molecular pathogenesis of MALT lymphoma K Troppan, K Wenzl, P Neumeister, A Deutsch Gastroenterology research and practice 2015, 2015 | 72 | 2015 |
| C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients KT Troppan, K Schlick, A Deutsch, T Melchardt, A Egle, T Stojakovic, ... British journal of cancer 111 (1), 55-60, 2014 | 63 | 2014 |
| miR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large B-cell lymphoma patients K Troppan, K Wenzl, M Pichler, B Pursche, D Schwarzenbacher, ... International journal of molecular sciences 16 (8), 18077-18095, 2015 | 62 | 2015 |
| NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas AJA Deutsch, B Rinner, K Wenzl, M Pichler, K Troppan, E Steinbauer, ... Blood, The Journal of the American Society of Hematology 123 (15), 2367-2377, 2014 | 53 | 2014 |
| MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy K Troppan, K Wenzl, A Deutsch, H Ling, P Neumeister, M Pichler Anticancer research 34 (2), 557-564, 2014 | 48 | 2014 |
| Amplification of 9p24. 1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma Y Wang, K Wenzl, MK Manske, YW Asmann, V Sarangi, PT Greipp, ... Blood cancer journal 9 (9), 73, 2019 | 45 | 2019 |
| Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma X Wu, M Stenson, J Abeykoon, K Nowakowski, L Zhang, J Lawson, ... Blood, The Journal of the American Society of Hematology 134 (4), 363-373, 2019 | 44 | 2019 |
| The significance of pretreatment anemia in the era of R‐IPI and NCCN‐IPI prognostic risk assessment tools: a dual‐center study in diffuse large B‐cell lymphoma patients KT Troppan, T Melchardt, A Deutsch, K Schlick, T Stojakovic, MD Bullock, ... European Journal of Haematology 95 (6), 538-544, 2015 | 38 | 2015 |
| Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma K Wenzl, MK Manske, V Sarangi, YW Asmann, PT Greipp, HR Schoon, ... Blood cancer journal 8 (10), 97, 2018 | 35 | 2018 |
| Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL KT Hartert, K Wenzl, JE Krull, M Manske, V Sarangi, Y Asmann, ... Leukemia 35 (2), 522-533, 2021 | 32 | 2021 |
| NR4A3 suppresses lymphomagenesis through induction of proapoptotic genes AJA Deutsch, B Rinner, M Pichler, K Prochazka, K Pansy, M Bischof, ... Cancer research 77 (9), 2375-2386, 2017 | 25 | 2017 |
| Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma K Troppan, S Hofer, K Wenzl, M Lassnig, B Pursche, E Steinbauer, ... PLoS One 10 (4), e0123922, 2015 | 24 | 2015 |
| The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma KT Troppan, T Melchardt, K Wenzl, K Schlick, A Deutsch, MD Bullock, ... Journal of Clinical Pathology 69 (4), 326-330, 2016 | 23 | 2016 |
| Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients JE Krull, K Wenzl, KT Hartert, MK Manske, V Sarangi, MJ Maurer, ... Blood cancer journal 10 (11), 117, 2020 | 22 | 2020 |
| Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma BA Manso, K Wenzl, YW Asmann, MJ Maurer, M Manske, ZZ Yang, ... Blood cancer journal 7 (4), e553-e553, 2017 | 12 | 2017 |
| Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas K Wenzl, S Hofer, K Troppan, M Lassnig, E Steinbauer, M Wiltgen, ... Tumor Biology 37, 4785-4789, 2016 | 11 | 2016 |
| molecular clusters and tumor-immune drivers of IgM monoclonal gammopathies P Mondello, J Paludo, JP Novak, K Wenzl, ZZ Yang, S Jalali, JE Krull, ... Clinical Cancer Research 29 (5), 957-970, 2023 | 4 | 2023 |
| Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma X Tang, ZZ Yang, HJ Kim, T Anagnostou, Y Yu, X Wu, J Chen, JE Krull, ... Clinical Cancer Research 28 (19), 4322-4335, 2022 | 4 | 2022 |
